SERPINE1 and cancer: Even though the use of the mRNA-based approach does not require fresh/fresh-frozen tissues, the incongruities between the studies to quantify and use the uPA and PAI-1 mRNAs as biomarkers for cancer patients prevented their use in clinical settings [34].